{"publish_date":{"6419764":20141013,"6436410":20141013},"url":{"6419764":"http:\/\/www.chicagotribune.com\/suburbs\/downers-grove-darien-westmont-woodridge\/community\/chi-ugc-article-ebola-emphasizes-need-to-know-medical-risks-2014-10-13-story.html","6436410":"http:\/\/www.wallstreet-online.de\/nachricht\/7076125-abbvie-announces-late-breaking-results-from-phase-3-trial-of-humira-adalimumab-hidradenitis-suppurativa-hs-patients-at-the-european-academy-of-dermatology-and-venereology-congress"},"topic":{"6419764":"hepat","6436410":"hepat"},"model1_prediction":{"6419764":1,"6436410":1},"model1_prediction_prob":{"6419764":0.8968955302,"6436410":0.650839742},"title":{"6419764":"Ebola emphasizes need to know medical risks, requirements before travel abroad","6436410":"AbbVie Announces Late-Breaking Results from Phase 3 Trial of HUMIRA\u00ae (adalimumab) in Hidradenitis Suppurativa (HS) Patients at the European Academy of Dermatology and Venereology Congress"}}